A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan

Name: A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan
Published: 2024
License: Public Domain

Novartis Pharmaceuticals · 2024

ClinicalTrials.gov · Datasets · License: Public Domain · 2024

Open Source ↗

pet-ct sensitivity specificity

neuroendocrine neoplasms, [68ga]ga-dota-tate, neuroendocrine neoplasms (nens), positron emission tomography (pet), computerized tomography (ct), pet/ct, diagnostic performance, sensitivity, specificity, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan

Related documents